330550-45-3Relevant academic research and scientific papers
Pteridinone derivative as RSK inhibitor and application thereof
-
Paragraph 0098; 0111-0115; 0122-0124, (2022/01/04)
The invention relates to a pteridinone derivative serving as an RSK protein kinase inhibitor and application thereof. Specifically, the invention relates to a compound as shown in a formula I, a pharmaceutical composition containing the compound as shown in the formula I and application of the compound in preparation of drugs for treating RSK related diseases or inhibiting RSK.
Pteridinones as kinase inhibitors
-
, (2008/06/13)
Disclosed are compounds of Formulae (Ia), (Ib), (Ic), (Id) wherein: W is NH, S, SO, or SO2; R2 is (un)substituted aryl, (un)substituted heteroaryl, or (un)substituted carbocycle or heterocycle; Q is hydrogen or lower alkyl; R4
